Finance

Lists
Why is 688319 down 4,19%?
Dive Deeper
688319:SHA
Chengdu Olymvax Biopharmaceuticals Inc
25,16 CN¥
-4,19%
(-1,10) 1D
19 հոկ, 10:23:39 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688319...
Open
26,40 CN¥
High
26,40 CN¥
Low
24,98 CN¥
Mkt. cap
10,65 մլրդ
Avg. vol.
6,21 մլն
Volume
1,94 մլն
52-wk high
44,90 CN¥
52-wk low
20,41 CN¥
EPS
-0,06 CN¥
No. of employees
436
Open
26,40 CN¥
High
26,40 CN¥
Low
24,98 CN¥
Mkt. cap
10,65 մլրդ
Avg. vol.
6,21 մլն
Volume
1,94 մլն
52-wk high
44,90 CN¥
52-wk low
20,41 CN¥
EPS
-0,06 CN¥
No. of employees
436
News stories
From web sources and news partners
About Chengdu Olymvax Biopharmaceuticals Inc
CEO-
Employees436
Founded11 դեկ, 2009 թ.
Headquarters-
Sector-
Websiteolymvax.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
201,07 մլն
197,24 մլն
157,80 մլն
203,52 մլն
Cost of goods sold
14,60 մլն
28,17 մլն
12,87 մլն
12,68 մլն
Cost of revenue
14,60 մլն
28,17 մլն
12,87 մլն
12,68 մլն
Research and development expenses
36,10 մլն
38,02 մլն
20,19 մլն
29,49 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
118,36 մլն
159,56 մլն
96,59 մլն
120,29 մլն
Operating expense
139,35 մլն
197,40 մլն
118,09 մլն
161,08 մլն
Total operating expenses
153,95 մլն
225,57 մլն
130,97 մլն
173,77 մլն
Operating income
47,12 մլն
-28,33 մլն
26,84 մլն
29,75 մլն
Other non operating income
-471,53 հզր
365,44 հզր
-173,54 հզր
148,37 հզր
EBT including unusual items
41,07 մլն
-23,86 մլն
32,42 մլն
-6,24 մլն
EBT excluding unusual items
43,58 մլն
-31,86 մլն
22,75 մլն
25,47 մլն
Income tax expense
7,15 մլն
1,39 մլն
5,22 մլն
53,84 մլն
Effective tax rate
17,41%
-5,84%
16,11%
-863,09%
Other operating expenses
828,21 հզր
2,75 մլն
2,61 մլն
3,56 մլն
Net income
34,28 մլն
-25,22 մլն
27,19 մլն
-60,06 մլն
Net profit margin
17,05%
-12,79%
17,23%
-29,51%
Earnings per share
-
-
-
-
Interest and investment income
235,35 հզր
290,12 հզր
205,06 հզր
98,07 հզր
Interest expense
-3,30 մլն
-4,17 մլն
-4,12 մլն
-4,47 մլն
Net interest expenses
-3,07 մլն
-3,88 մլն
-3,92 մլն
-4,37 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
54,11 մլն
-19,96 մլն
35,20 մլն
39,45 մլն
Gain or loss from assets sale
8,71 հզր
-8,71 հզր
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps